199PAnti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study. (23rd October 2018) - Prat, A; Adamo, B; Perez Fidalgo, J A; Blanch, S; Martinez, N; Gomez Pardo, P; López González, A; Murillo Juso, L; Amillano, K; Vidal, M; Pascual, T; Pare, L; et al.